Screening Libraries
What is a Bioactive Screening Library?
The libraries consist of a unique and diverse collection of over 2,500 small molecules with validated biological and pharmacological activities Safety and effectiveness of the compounds has been demonstrated by preclinical and clinical research, and many of the compounds are FDA-approved. The collections of unique small molecules, which include inhibitors, activators, antagonists, and agonists, are focused on over 200 targets that are part of more than 20 signaling pathways . These pathways include, among many others, apoptosis, and the PI3K/Akt/mTOR, and MAPK pathways. Selleck offers customized bioactive screening libraries , whereby you choose the specific compounds you want in the library, the quantities, plate map, concentration, and format (dry/solid or DMSO solution).
Compound Library Advantages
Structurally diverse, medicinally active, and cell permeable
Rich documentation with structure, IC50, and customer reviews
NMR and HPLC validated to ensure high purity
You can select compounds, quantities, format (dry/solid or DMSO) and plate map to meet your specific requirement.
-
FDA-approved Drug Library
A unique collection of 1953 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS).
-
Clinical Compound Library
A unique collection of 621 clinical compounds for high throughput screening (HTS) and high content screening (HCS).
-
Bioactive Compound Library-I
A unique collection of 4718 bioactive chemical compounds for high throughput screening (HTS) and high content screening (HCS).
-
Bioactive Compound Library-Ⅱ（Provided by Pfizer）
A unique collection of 3000 bioactive chemical compounds for high throughput screening (HTS) and high content screening (HCS).
-
Kinase Inhibitor Library
A unique collection of 644 kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).
-
Express-Pick Library (Provided by Pfizer)
A unique collection of 4208 chemical compounds featured different core structures and structural diversities respectively for high throughput screening (HTS) and high content screening (HCS).
-
Natural Product Library
A unique collection of 1621 natural products for high throughput screening (HTS) and high content screening (HCS).
-
Metabolism Compound Library
A unique collection of 513 small molecules with biological activity in numerous metabolic pathway: glycometabolism, lipid metabolism, proteolysis, etc.
-
Target Selective Inhibitor Library
A unique collection of 641 validated bioactive compounds covering over 174 targets.
-
Epigenetics Compound Library
Selleck Epigenetic inhibitor Library contains various small molecule modulators (inhibitors and activators) with biological activity used for epigenetic research and associated assays.
-
Stem Cell Signaling Compound Library
Selleck Stem Cell Small Molecule Compound Library contains various small molecule inhibitors with biological activity used for stem cell regulatory and signaling pathway research.
-
Inhibitor Library
A unique collection of 2246 inhibitors for high throughput screening (HTS) and high content screening (HCS).
-
Apoptosis Compound Library
A unique collection of 142 small molecules used for apoptosis research targeting Bcl-2,Caspase,p53,TNF-alpha,Mdm2,survivin, etc.
-
FDA-approved Drug Library(Simplified Edition)
A unique collection of 1855 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS)
-
GPCR Compound Library
Selleck GPCR Small Molecule Compound Library contains various small molecules targeting G protein coupled receptors with biological activity.
-
Cambridge Cancer Compound Library
A unique collection of 247 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS).
-
Immunology/Inflammation Compound Library
A unique collection of 413 small molecules modulators (inhibitors and activators) with biological activity used for Immunology/Inflammation research and associated assays.
-
Drug Repurposing Library
A unique collection of 2339 drugs that are marketed around the world or that have passed phase 1 clinical trials for high throughput screening (HTS) and high content screening (HCS).
-
Pfizer Licensed Compound Library
Selleck and Pfizer are proud to present a unique collection of 81 drug compounds licensed by Pfizer.
-
MAPK Inhibitor Library
A unique collection of 77 small molecule inhibitors used for MAPK signaling research.
-
Fragment Library
A unique collection of 1015 Fragment compounds for Fragment-Based Drug Discovery (FBDD).
-
Neuronal Signaling Compound Library
A unique collection of 684 small molecule compounds with biological activity used for neurologic research and associated assays
-
PI3K/Akt Inhibitor Library
A unique collection of 141 small molecule inhibitors used for PI3K/Akt/mTOR pathway research.
-
Anti-diabetic Compound Library
A unique collection of 49 small molecules affecting the development of diabetes.
-
Anti-infection Compound Library
A unique collection of 477 anti-infective small molecules with biological activity of antibiotics,antifungal drugs,anti-HIV,etc.
-
Anti-cancer Compound Library
A unique collection of 1180 anti-cancer small molecules for 12 types of cancers: Breast Cancer, Leukemia, Lung Cancer, Lymphoma, etc.
-
Tyrosine Kinase Inhibitor Library
Tyrosine Kinase Inhibitor library is ideal database for high-throughput screening (HTS) and cell based high-content screening (HCS).
-
Ion Channel Ligand Library
A unique collection of 116 small molecule modulators used for Ion channel research.
-
Protease Inhibitor Library
A unique collection of 78 small molecule inhibitors used for chemical genomics, high-throughput screening (HTS), and high content screening (HCS).
-
Autophagy Compound Library
A unique collection of 187 small molecules with autophagy-inducing or autophagy-inhibiting activity.
-
Bioactive Compound Library(Simplified Edition)
A unique collection of 4489 bioactive chemical compounds for high throughput screening (HTS) and high content screening (HCS)
-
Express-Pick Library (Premium Version)
A unique collection of 111430 innovative compounds features numerous structurally diverse compounds and several alternate compositions.
-20170221.gif)
